|
DK114394B
(da)
|
1963-06-17 |
1969-06-23 |
O Hoyer |
Fremgangsmåde ved emballering af aflange formlegemer, navnlig ispinde, samt maskine til udøvelse af fremgangsmåden.
|
|
US3331526A
(en)
|
1964-07-20 |
1967-07-18 |
Levenson Leonard Lionel |
Ultrahigh vacuum seal
|
|
US3270877A
(en)
|
1965-06-18 |
1966-09-06 |
Hanns E Hecker |
Package for columnar articles
|
|
US3589511A
(en)
|
1969-08-13 |
1971-06-29 |
Owens Illinois Inc |
Package and tray for tubes or the like
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
EP0247730A3
(en)
|
1986-04-28 |
1989-04-12 |
Antibody Technology Limited |
Antibodies, their preparation and use and products containing them
|
|
US5167638A
(en)
|
1989-10-27 |
1992-12-01 |
C. R. Bard, Inc. |
Subcutaneous multiple-access port
|
|
US5834005A
(en)
|
1992-02-24 |
1998-11-10 |
Encelle, Inc. |
Bioartificial devices and cellular matrices therefor
|
|
EP0750516A4
(en)
*
|
1993-03-26 |
1998-07-01 |
Univ Jefferson |
METHOD FOR INHIBITING CELL PROLIFERATION AND TRIGGERING CELL DIFFERENTIATION USING TYPE 1 GROWTH FACTOR RECEPTOR OLIGONUCLEOTIDES
|
|
US6340674B1
(en)
|
1993-03-26 |
2002-01-22 |
Thomas Jefferson University |
Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
EP0647450A1
(en)
|
1993-09-09 |
1995-04-12 |
BEHRINGWERKE Aktiengesellschaft |
Improved prodrugs for enzyme mediated activation
|
|
US5714170A
(en)
|
1994-11-16 |
1998-02-03 |
Thomas Jefferson University |
Method of inducing resistance to tumor growth
|
|
JPH08336393A
(ja)
|
1995-04-13 |
1996-12-24 |
Mitsubishi Chem Corp |
光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
|
|
US6218519B1
(en)
|
1996-04-12 |
2001-04-17 |
Pro-Neuron, Inc. |
Compounds and methods for the selective treatment of cancer and bacterial infections
|
|
EP0961619A4
(en)
|
1996-09-27 |
2001-09-26 |
Bristol Myers Squibb Co |
HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS
|
|
US6759509B1
(en)
|
1996-11-05 |
2004-07-06 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US6071891A
(en)
|
1996-11-22 |
2000-06-06 |
Regents Of The University Of Minnesota |
Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition
|
|
US6541036B1
(en)
|
1997-05-29 |
2003-04-01 |
Thomas Jefferson University |
Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR)
|
|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
HK1040052B
(zh)
|
1998-05-22 |
2006-09-15 |
第一制药株式会社 |
药物复合物
|
|
JP2002522506A
(ja)
*
|
1998-08-13 |
2002-07-23 |
トーマス・ジェファーソン・ユニバーシティ |
インスリン様増殖因子−ｉ受容体に向けられるオリゴヌクレオチドを用いた腫瘍の処置
|
|
GB9818731D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Compounds
|
|
US6144553A
(en)
|
1998-09-09 |
2000-11-07 |
Sun Microsystems, Inc. |
Refrigeration cooled disk storage assembly
|
|
US6268488B1
(en)
|
1999-05-25 |
2001-07-31 |
Barbas, Iii Carlos F. |
Prodrug activation using catalytic antibodies
|
|
IL134009A
(en)
|
2000-01-12 |
2011-07-31 |
Bo2 Technologies Ltd |
Transplant device
|
|
US20040052793A1
(en)
|
2001-02-22 |
2004-03-18 |
Carter Paul J. |
Caspase activivated prodrugs therapy
|
|
WO2002027019A1
(en)
|
2000-09-29 |
2002-04-04 |
The Johns Hopkins University School Of Medicine |
Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
|
|
US20040018194A1
(en)
|
2000-11-28 |
2004-01-29 |
Francisco Joseph A. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
EP1243276A1
(en)
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
WO2003026577A2
(en)
|
2001-09-24 |
2003-04-03 |
Seattle Genetics, Inc. |
P-amidobenzylethers in drug delivery agents
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
CA2467242A1
(en)
|
2001-11-20 |
2003-05-30 |
Seattle Genetics, Inc. |
Treatment of immunological disorders using anti-cd30 antibodies
|
|
AU2003294210A1
(en)
|
2002-07-31 |
2004-05-04 |
Seattle Genetics, Inc |
Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders
|
|
AU2003256038A1
(en)
|
2002-08-30 |
2004-03-19 |
Ramot At Tel Aviv University Ltd. |
Self-immolative dendrimers releasing many active moieties upon a single activating event
|
|
JP2006507322A
(ja)
|
2002-11-14 |
2006-03-02 |
シンタルガ・ビーブイ |
多重自己脱離放出スペーサーとして構築されたプロドラッグ
|
|
US7037335B2
(en)
|
2002-11-19 |
2006-05-02 |
Eagle Vision, Inc. |
Bulbous scleral implants for the treatment of eye disorders such as presbyopia and glaucoma
|
|
WO2004072284A1
(en)
|
2003-02-11 |
2004-08-26 |
Antisense Therapeutics Ltd |
Modulation of insulin like growth factor i receptor expression
|
|
US7846906B2
(en)
|
2003-02-28 |
2010-12-07 |
Isis Pharmaceuticals, Inc. |
Modulation of growth hormone receptor expression and insulin-like growth factor expression
|
|
US20050043233A1
(en)
|
2003-04-29 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
|
|
CA2447400A1
(en)
|
2003-09-12 |
2005-03-12 |
The Hospital For Sick Children |
Brain tumor stem cells
|
|
EP2905033B1
(en)
|
2003-12-16 |
2020-09-02 |
Nektar Therapeutics |
Monodisperse PEGylated naloxol compositions
|
|
EP1720908A2
(en)
|
2004-02-17 |
2006-11-15 |
Absalus, Inc. |
Super-humanized antibodies against respiratory syncytial virus
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
US7361168B2
(en)
|
2004-04-21 |
2008-04-22 |
Acclarent, Inc. |
Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
|
|
KR101270829B1
(ko)
|
2004-09-23 |
2013-06-07 |
제넨테크, 인크. |
시스테인 유전자조작 항체 및 접합체
|
|
NZ554831A
(en)
|
2004-11-09 |
2009-10-30 |
Schering Corp |
Improved dosing regimen of temozolomide for treating cancer based on the patientÆs MGMT level
|
|
ES2417133T3
(es)
|
2005-02-03 |
2013-08-06 |
Antitope Limited |
Anticuerpos y proteínas humanas
|
|
HRP20110498T1
(hr)
|
2005-10-07 |
2011-08-31 |
Exelixis |
Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
|
|
SI1813614T1
(sl)
|
2006-01-25 |
2012-01-31 |
Sanofi 174 |
Citotoksična sredstva, ki obsegajo nove tomajmicinske derivate
|
|
EP1900825A1
(en)
|
2006-09-13 |
2008-03-19 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Sensitive and reproducible method for the determination of MGMT promoter methylation in clinical samples
|
|
EP2144628B1
(en)
|
2007-05-08 |
2012-10-17 |
Genentech, Inc. |
Cysteine engineered anti-muc16 antibodies and antibody drug conjugates
|
|
MX2010003718A
(es)
|
2007-10-19 |
2010-04-21 |
Genentech Inc |
Anticuerpos anti-tenb2 producidos por ingenieria de cisteina y conjugados de farmaco y anticuerpo.
|
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
|
US9446168B2
(en)
|
2010-06-07 |
2016-09-20 |
Beta-O2 Technologies Ltd. |
Multiple-layer immune barrier for donor cells
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
FI123146B
(fi)
|
2009-10-01 |
2012-11-30 |
Bayer Schering Pharma Oy |
Kohdunsisäinen järjestelmä
|
|
CA2783665A1
(en)
|
2010-03-03 |
2011-09-09 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
DK2528625T3
(da)
|
2010-04-15 |
2013-10-14 |
Spirogen Sarl |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
US8697688B2
(en)
|
2010-04-15 |
2014-04-15 |
Seattle Genetics Inc. |
Pyrrolobenzodiazepines used to treat proliferative diseases
|
|
WO2011130615A2
(en)
|
2010-04-15 |
2011-10-20 |
Dr. Reddy's Laboratories Ltd. |
Preparation of lacosamide
|
|
MX391454B
(es)
|
2010-04-15 |
2025-03-05 |
Seagen Inc |
Compuesto de engarce-fármaco para conjugación a una unidad de ligando.
|
|
CA2812707C
(en)
|
2010-09-27 |
2020-02-18 |
Gloriana Therapeutics Sarl |
Implantable cell device with supportive and radial diffusive scaffolding
|
|
ES2677070T3
(es)
|
2010-10-27 |
2018-07-27 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con el regulador del desarrollo 1 asociado a interferón (ifrd1) mediante inhibición del transcrito antisentido natural al gen ifrd1
|
|
EP2567905A1
(en)
|
2011-09-09 |
2013-03-13 |
Becton Dickinson France |
Tray and packaging for medical containers
|
|
JP2015521602A
(ja)
|
2012-06-14 |
2015-07-30 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
核受容体リガンドポリペプチドに対して複合化されている抗ｐｓｍａ抗体
|
|
CN102898426B
(zh)
*
|
2012-11-15 |
2015-04-22 |
江苏先声药业有限公司 |
抑制igf-1r酪氨酸激酶活性的吡啶并吡唑类衍生物
|
|
EP2988699B1
(en)
|
2013-04-24 |
2020-05-27 |
Société des Produits Nestlé S.A. |
Encapsulation device
|
|
US9539757B2
(en)
|
2013-06-26 |
2017-01-10 |
Tekni-Plex, Inc. |
Packing tray having cell pockets with expandable sidewalls and floating base, and method of manufacture
|
|
WO2015035365A1
(en)
|
2013-09-09 |
2015-03-12 |
The Nohns Hopkins University |
Targeting the m2-tumor associated macrophage for cancer therapy
|
|
CN105792775B
(zh)
|
2013-09-24 |
2019-02-19 |
吉纳生命科学公司 |
用于细胞植入物的气体处理的系统
|
|
AU2014375206B2
(en)
|
2014-01-03 |
2021-09-30 |
Innosign B.V. |
Assessment of the PI3K cellular signaling pathway activity using mathematical modelling of target gene expression.
|
|
US9872674B2
(en)
|
2014-05-07 |
2018-01-23 |
Boehringer Laboratories Inc. |
Entrapment and containment system for use with a morcellator and method of entrapping and containing material produced during morcellation procedure
|
|
WO2016164916A1
(en)
|
2015-04-10 |
2016-10-13 |
Thomas Jefferson University |
Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory m2 monocytes
|
|
CA3250034A1
(en)
|
2015-04-23 |
2025-10-30 |
Applied Medical Resources Corporation |
Systems and methods for tissue removal
|
|
ES2887273T3
(es)
|
2015-06-29 |
2021-12-22 |
Immunogen Inc |
Anticuerpos anti-CD123 y conjugados y derivados de los mismos
|
|
CN108291227A
(zh)
|
2015-10-14 |
2018-07-17 |
拜奥-帕斯控股股份有限公司 |
用于脂质体制剂的对乙氧基核酸
|
|
US10357509B2
(en)
*
|
2017-03-09 |
2019-07-23 |
Thomas Jefferson University |
Methods and compositions for treating cancers using antisense
|
|
CA3060090A1
(en)
|
2017-04-19 |
2018-10-25 |
Bio-Path Holdings, Inc. |
P-ethoxy nucleic acids for igf-1r inhibition
|
|
CA3089583A1
(en)
|
2018-01-24 |
2019-08-01 |
Thomas Jefferson University |
Biodiffusion chamber
|
|
EP4031465B1
(en)
|
2019-09-19 |
2026-01-28 |
Thomas Jefferson University |
Apparatus and methods for biodiffusion chamber storage
|
|
CA3171914A1
(en)
|
2020-03-18 |
2021-09-23 |
Vincent Ling |
Implantable cell chamber device and uses thereof
|
|
JP2023521400A
(ja)
|
2020-04-09 |
2023-05-24 |
デファイメッド |
医療デバイス用の膜
|